Neurotrophins in Carotid Atherosclerosis and Stenting

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2023 Jan 10

PMID 36625566

Authors

Teodora Yaneva-Sirakova

Latchezar Traykov

Kiril Karamfiloff

Ivo Petrov

Julieta Hristova

Dobrin Vassilev

Affiliations

Soon will be listed here.

Abstract

Introduction: Carotid stenting is used with an expanding indications. The neurotrophins are a family of proteins that induce the survival, development, and function of neurons. Carotid stenting alters cerebral blood flow and can affect neurotrophins' levels.

Material And Methods: We included 78 people: 39 with significant carotid stenoses (CS) referred for carotid stenting (mean age 67.79 ± 10.53 years) and relatively healthy control group of 39 people without carotid and vertebral artery disease (mean age 57.42 ± 15.77 years). Brain derived reurotrophic factor (BDNF) and neuronal growth factor (NGF) concentrations were evaluated with ELISA method from venous blood - once for the control group; and for the carotid stenting group: before (n33), 24 h after (n22) and at least 1 month after (n18) carotid stenting.

Results: There was a difference between the mean neurotrophins' concentration of patients with significant carotid stenoses and the group without: BDNF = 0.001, CI (-5.11 to -1.44) (3.10 ± 3.10 ng/ml in CS vs. 6.37 ± 4.67 ng/ml in controls); NGF = 0.049, CI (0.64-347.75), 195.67 ± 495.34 pg/ml in CS vs. 21.48 ± 52.81 pg/ml in controls. BDNF levels before carotid stenting (3.10 ± 3.10 ng/ml) were significantly lower than the postprocedural (4.99 ± 2.57 ng/ml) - < 0.0001, CI (-2.86 to -0.99). For NGF there was a tendency for lower values after stenting: 195.67 ± 495.34 pg/ml before vs. 94.92 ± 120.06 pg/ml after, but the result did not reach statistical significance. The neurotrophins levels one month after carotid stenting and controls' were not significantly different < 0.01 (BDNF 5.03 ± 4.75 ng/ml vs. 6.37 ± 4.67 ng/min; NGF 47.89 ± 54.68 pg/ml vs. 21.48 pg/ml).

Discussion And Conclusion: Periprocedural and mid-term concentrations of neurotrophins after carotid stenting change in non-linear model. This may be due to changes in cerebral perfusion and also might be involved in neuronal recovery and reparation after reperfusion.KEY MESSAGESPeriprocedural and mid-term concentrations of neurotrophins after carotid stenting change in non-linear model.As the majority of them are not specific, their periprocedural change can be used as a clinical correlate to guide changes or even success in carotid stenting.Changes in neutrophins' concentrations may be due to changes in cerebral perfusion and also might be involved in neuronal recovery and reparation after reperfusion.This goes in analogy with cardiac high-sensitive troponin, used as procedural guidance in coronary interventions.

References

Ziegler L, Lundqvist J, Dreij K, Wallen H, de Faire U, Paulsson-Berne G . Expression of Interleukin 6 signaling receptors in carotid atherosclerosis. Vasc Med. 2020; 26(1):3-10. PMC: 7879223. DOI: 10.1177/1358863X20977662. View

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2020; 44(Suppl 1):S15-S33. DOI: 10.2337/dc21-S002. View

Bonati L, Kakkos S, Berkefeld J, de Borst G, Bulbulia R, Halliday A . European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021; 6(2):I-XLVII. PMC: 8370069. DOI: 10.1177/23969873211012121. View

Li Q, Cui J, Fang C, Zhang X, Li L . S-adenosylmethionine Administration Attenuates Low Brain-Derived Neurotrophic Factor Expression Induced by Chronic Cerebrovascular Hypoperfusion or Beta Amyloid Treatment. Neurosci Bull. 2016; 32(2):153-61. PMC: 5563744. DOI: 10.1007/s12264-016-0023-z. View

Lindvall O, Ernfors P, Bengzon J, Kokaia Z, Smith M, Siesjo B . Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci U S A. 1992; 89(2):648-52. PMC: 48296. DOI: 10.1073/pnas.89.2.648. View

Alomari M, Khabour O, Maikano A, Alawneh K . Vascular function and brain-derived neurotrophic factor: The functional capacity factor. Vasc Med. 2015; 20(6):518-26. DOI: 10.1177/1358863X15598390. View

Luan X, Qiu H, Hong X, Wu C, Zhao K, Chen H . High serum nerve growth factor concentrations are associated with good functional outcome at 3 months following acute ischemic stroke. Clin Chim Acta. 2018; 488:20-24. DOI: 10.1016/j.cca.2018.10.030. View

Huang E, Reichardt L . Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001; 24:677-736. PMC: 2758233. DOI: 10.1146/annurev.neuro.24.1.677. View

Lal B, Hobson 2nd R, Tofighi B, Kapadia I, Cuadra S, Jamil Z . Duplex ultrasound velocity criteria for the stented carotid artery. J Vasc Surg. 2008; 47(1):63-73. DOI: 10.1016/j.jvs.2007.09.038. View

10.

Eftimiadi G, Soligo M, Manni L, Di Giuda D, Calcagni M, Chiaretti A . Topical delivery of nerve growth factor for treatment of ocular and brain disorders. Neural Regen Res. 2021; 16(9):1740-1750. PMC: 8328750. DOI: 10.4103/1673-5374.306062. View

11.

. Chapter 6: Triglyceride-lowering treatment in children. Kidney Int Suppl (2011). 2014; 3(3):286. PMC: 4089643. DOI: 10.1038/kisup.2013.38. View

12.

Aboyans V, Ricco J, Bartelink M, Bjorck M, Brodmann M, Cohnert T . 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric,.... Eur Heart J. 2017; 39(9):763-816. DOI: 10.1093/eurheartj/ehx095. View

13.

Lee T, Kato H, Chen S, Kogure K, Itoyama Y . Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke. 1998; 29(8):1687-96; discussion 1697. DOI: 10.1161/01.str.29.8.1687. View

14.

Donovan M, HEMPSTEAD B, Huber L, KAPLAN D, Tsoulfas P, Chao M . Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors. Am J Pathol. 1994; 145(4):792-801. PMC: 1887328. View

15.

. Corrigendum to: 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12.... Eur Heart J. 2022; 43(42):4468. DOI: 10.1093/eurheartj/ehac458. View

16.

Cui B, Wu C, Chen L, Ramirez A, Bearer E, Li W . One at a time, live tracking of NGF axonal transport using quantum dots. Proc Natl Acad Sci U S A. 2007; 104(34):13666-71. PMC: 1959439. DOI: 10.1073/pnas.0706192104. View

17.

Rauti R, Cellot G, DAndrea P, Colliva A, Scaini D, Tongiorgi E . BDNF impact on synaptic dynamics: extra or intracellular long-term release differently regulates cultured hippocampal synapses. Mol Brain. 2020; 13(1):43. PMC: 7079446. DOI: 10.1186/s13041-020-00582-9. View

18.

Fawcett J, Bamji S, Causing C, Aloyz R, Ase A, Reader T . Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci. 1998; 18(8):2808-21. PMC: 6792589. View

19.

Trojanowska A, Drop A, Jargiello T, Wojczal J, Szczerbo-Trojanowska M . Changes in cerebral hemodynamics after carotid stenting: evaluation with CT perfusion studies. J Neuroradiol. 2006; 33(3):169-74. DOI: 10.1016/s0150-9861(06)77255-8. View

20.

Song J, Liu Z, Sui L, Zhang B, Zhao Y, Ma X . Dynamic expression of nerve growth factor and its receptor TrkA after subarachnoid hemorrhage in rat brain. Neural Regen Res. 2016; 11(8):1278-84. PMC: 5020827. DOI: 10.4103/1673-5374.189193. View